Clinical Trials of TCDD
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2003-04-01
|
| Series: | Dose-Response |
| Online Access: | https://doi.org/10.1080/15401420391434298 |
| id |
doaj-3d5e3e077ad547068ae5ceab50c87822 |
|---|---|
| record_format |
Article |
| spelling |
doaj-3d5e3e077ad547068ae5ceab50c878222020-11-25T02:34:07ZengSAGE PublishingDose-Response1559-32582003-04-01110.1080/15401420391434298Clinical Trials of TCDDGary Kayajanianhttps://doi.org/10.1080/15401420391434298 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Gary Kayajanian |
| spellingShingle |
Gary Kayajanian Clinical Trials of TCDD Dose-Response |
| author_facet |
Gary Kayajanian |
| author_sort |
Gary Kayajanian |
| title |
Clinical Trials of TCDD |
| title_short |
Clinical Trials of TCDD |
| title_full |
Clinical Trials of TCDD |
| title_fullStr |
Clinical Trials of TCDD |
| title_full_unstemmed |
Clinical Trials of TCDD |
| title_sort |
clinical trials of tcdd |
| publisher |
SAGE Publishing |
| series |
Dose-Response |
| issn |
1559-3258 |
| publishDate |
2003-04-01 |
| url |
https://doi.org/10.1080/15401420391434298 |
| work_keys_str_mv |
AT garykayajanian clinicaltrialsoftcdd |
| _version_ |
1724810110685937664 |